Member Info for Celtic007

Great find Ben

Management was surprised by the toxicology finding and hadn’t expected it to happen from deal diligence, the analysts said, but the biotech also framed the setback as one of the risks of buying assets before validatory clinical data drive up the price.

Last paragraph sums it up best...the risks we take by doing these toxicity tests but the risks big pharmaceutical take by not moving early

At this stage any big buying for me would be maybe indicating chk1 news, which we know is imminent. Any other big news, regarding other molecules not any nearer I think.

Aim is corrupt but true value of this will come out. Next big news regarding chk1 or this peer review

Hi abyer. Look at Matt posting history and says it all. Would not say a derampers, but what I call playing this like a banjo up and down to make a few quid, which is ok but the posting of negative followed by positive followed in a while negative, says it all.

Nice to have you back citizen and sorry and condolences

I think the toxicity test will be make or break as potnak said , and am happy for that. I want to know if safe, as that is a big big advantage over other licenced ones.

A bit of russian roulette....fire the gun I say, as I think we will be fine.

Thanks krone

Hi krone. Hope you are ok mate. Why treeline? Because of their aggressive cancer research outside the norm?

Hi sadoldgit. Hope you are ok mate. Do you think the peer review of data coming will be a important step, as be independently reviewed ?

Thanks sadoldgit. Appreciated.

Enki, we all appreciate sadoldgit contribution, as he does not copy and paste and puts of time into his posts , like Thoth.

So please keep quiet FFS .

Robo and James very quiet....as I said short it. This will either get taken out at a good price or merged ...fireworks as lots of high wealth investors in

Great post Simon. MA wants this to merge with boohoo and he knows a good thing. This is really a win win at these price, as it will get taken out and when it does , will get hostile to our benefit. I bought these at £4.50, as o happy .

You can tell you are crapping yourself Roberto ....shorts closing son

Roberto is a fool, but expect you to defend him. Short this please ...I dare you

Roberto is a fool, but expect you to defend him. Short this please ...I dare you

Agree peer review important as be validated by outside experts and spoken about on the pharmaceutical world....important step

The only pain is you Roberto the tool

I also think a takeover and think great. We do the toxicity study and take all the risk. Great I say....this type of approach is risky but confident but also let's the interested parties know that we are not scared to go alone and if we are right, then the big money goes up exponentially.

Agree leggester. We have a clear pathway and we could have taken a ridiculous low offer and all hell would have broken here, as management would have been told , that crap at deal making and done a similar crap deal like RF. Well they did not, and well done I say.

Good post sadoldgit but have a cold drink. We all getting frustrated here lol ...like being locked in a room with family.